Document Type : Original Article
Authors
- Sayed Mohammad Hashemi Jazi 1, 2
- Ehsan Shirvani 3
- Asieh Mansouri 4
- Mohammad Kermani-Alghoraishi 3
- Armin Bordbar 5
- Fereshte Sattar 6
- Ali Safaei 7
- Hossein Farshidi 8
- Ahmad Reza Assareh 9
- Toba Kazemi 10
- Alireza Khosravi 4
1 Department of Biostatistics and Epidemiology, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
2 School of Medicine, Department of Cardiology, Isfahan University of Medical Sciences, Isfahan, Iran
3 Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
4 Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
5 Department of Cardiology, Musavi Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
6 Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
7 Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
8 Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
9 Atherosclerosis Research Center, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
10 Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
Abstract
BACKGROUND: The National Persian Registry of Cardiovascular Disease (N-PROVE) has been established to provide a comprehensive database of cardiovascular diseases in the Iranian community for further investigations and to develop national guidelines for the diagnosis, treatment, and prevention of cardiovascular disease (CVD). As with most clinical registries, a quality control audit is necessary to ensure a comprehensive and accurate registry; the current study aims to assess the validity and quality of the N-PROVE/Angiography/Percutaneous Coronary Intervention (PCI) registry.
METHODS: The current cross-sectional quality assessment study serves as an example of data quality assessment in N-PROVE on a sample of patients registered in the N-PROVE/Angiography/PCI registry since 2020. Accordingly, data of 194 patients, including comorbidities, angiography, and angioplasty characteristics, were collected from the N-PROVE/Angiography/PCI registry as the main database and reevaluated by a panel consisting of a cardiologist and two coronary intervention fellowships as a test database.
RESULTS: The quality control of the population-based healthcare database, the N-PROVE/PCI, revealed that the average error rate in terms of comorbidities, angiography characteristics, angioplasty characteristics, and in total were 3.8%, 2.3%, 3%, and 3.03%, respectively.
CONCLUSION: According to the findings of this study, the N-PROVE/PCI registry had an average error of less than 4% in the assessed dimensions, including comorbidities, angiography, and angioplasty characteristics. Therefore, this registry appears valid and may be used for contemporary epidemiological studies.
Keywords
2. Jollis JG, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB. Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research. Ann Intern Med. 1993 Oct 15;119(8):844-50. https://doi.org/10.7326/0003-4819-119-8-199310150-00011
3. Shahian DM, Silverstein T, Lovett AF, Wolf RE, Normand SL. Comparison of clinical and administrative data sources for hospital coronary artery bypass graft surgery report cards. Circulation. 2007 Mar 27;115(12):1518-27. https://doi.org/10.1161/circulationaha.106.633008
4. AHRQ Methods for Effective Health Care. In Registries for Evaluating Patient Outcomes: A User’s Guide, Gliklich, R. E.; Dreyer, N. A.; Leavy, M. B., Eds. Agency for Healthcare Research and Quality (US): Rockville (MD), 2014.
5. Wennberg JE, Roos N, Sola L, Schori A, Jaffe R. Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy. JAMA. 1987 Feb 20;257(7):933-6.
6. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011 Jul;39(7 Suppl):22-5. https://doi.org/10.1177/1403494810387965
7. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006 Nov;53(4):441-9.
8. Rasmussen LA, Bøtker HE, Jensen LO, Ravkilde J, Riber L, Nielsen PH. Quality assurance of the Western Denmark Heart Registry, a population-based healthcare register. Dan Med J. 2017 Oct;64(10):A5414.
9. Schmidt M, Maeng M, Jakobsen CJ, Madsen M, Thuesen L, Nielsen PH. Existing data sources for clinical epidemiology: The Western Denmark Heart Registry. Clin Epidemiol. 2010 Aug 9;2:137-44. https://doi.org/10.2147%2Fclep.s10190
10. Colantonio LD, Muntner P. It Is Time for Reducing Global Cardiovascular Mortality. Circulation. 2019 Aug 27;140(9):726-28. https://doi.org/10.1161/circulationaha.119.041653
11. Givi M, Sarrafzadegan N, Garakyaraghi M, Yadegarfar G, Sadeghi M, Khosravi A. Persian Registry Of cardioVascular diseasE (PROVE): Design and methodology. ARYA Atheroscler. 2017 Sep;13(5):236-44.
12. de la Torre Hernández JM, Edelman ER. From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Research. Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1121-33. https://doi.org/10.1016/j.rec.2017.07.008
13. Cid Álvarez AB, Rodríguez Leor O, Moreno R, Pérez de Prado A. Spanish Cardiac Catheterization and Coronary Intervention Registry. 27th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2017). Rev Esp Cardiol (Engl Ed). 2018 Dec;71(12):1036-46. https://doi.org/10.1016/j.rec.2018.09.009
14. Özcan C, Juel K, Flensted Lassen J, von Kappelgaard LM, Mortensen PE, Gislason G. The Danish Heart Registry. Clin Epidemiol. 2016 Oct 25;8:503-508. https://doi.org/10.2147%2FCLEP.S99475
15. Khosravi A, Mansouri A, Shahsanayi F, Paydari N, Heshmat-Ghahdarijani K, Mansourian M, et al. Rationale and Design of the Persian CardioVascular Disease Registry (PCVDR): Scale-Up of Persian Registry Of CardioVascular DiseasE (PROVE). Curr Probl Cardiol. 2021 Mar;46(3):100577. https://doi.org/10.1016/j.cpcardiol.2020.100577
16. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988;41(2):105-14. https://doi.org/10.1016/0895-4356(88)90084-4
17. Ludman PF; British Cardiovascular Intervention Society. British Cardiovascular Intervention Society Registry for audit and quality assessment of percutaneous coronary interventions in the United Kingdom. Heart. 2011 Aug;97(16):1293-7. https://doi.org/10.1136/heartjnl-2011-300299
)